WOCKPHARMA.BOWOCKPHARMA.BOBSE
Loading
SG&A Expenses Over TimeStable
Percentile Rank29
3Y CAGR-4.5%
5Y CAGR-3.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-4.5%/yr
vs -7.6%/yr prior
5Y CAGR
-3.2%/yr
Consistent
Acceleration
+3.1pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
2025$6.53B+3.7%
2024$6.30B-1.3%
2023$6.38B-15.0%
2022$7.51B-5.3%
2021$7.93B+2.9%
2020$7.70B-13.9%
2019$8.94B-13.1%
2018$10.29B-2.4%
2017$10.54B+1.5%
2016$10.39B-